• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by GENENTA SCIENCE SPA

News headline image
Genenta signs Definitive Agreements with Sophia High Tech
April 23, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs
March 27, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini
March 24, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University
March 13, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform
February 27, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator
January 27, 2026
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Science Provides Update on CEO Ownership
December 19, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
November 24, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares
October 26, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production
October 24, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces Long-Term Follow-Up Observations in Brain Tumor (GBM) Study with Emerging Survival Signals
July 01, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
April 15, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
March 19, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
January 09, 2025
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta’s CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective”
October 23, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
October 02, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
May 06, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers ARYD GNTA SQZ
News headline image
Genenta Demonstrated Reprogramming of the Tumor Microenvironment in GBM Patients, Paving the Way for Innovative Treatments of Solid Tumors
February 08, 2024
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta to Present at Upcoming Scientific and Investor Conferences
September 06, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces Ongoing Clinical Trial Progress and Proposed Expansion in Solid Tumor Treatments
July 28, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
June 29, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta to Provide Update on Lead Product Temferon™
May 16, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
News headline image
Genenta Announces Fiscal Year 2022 Financial Results and Annual Report on Form 20-F Filing
April 26, 2023
From GENENTA SCIENCE SPA
Via GlobeNewswire
Tickers GNTA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap